Celestial Biolabs Limited reported audited earnings results for the fourth quarter and full year ended March 31, 2018. For the quarter, the company reported sales/income from operations of INR 163.574 million compared to INR 129.664 million a year ago. Profit from operations before other Income, finance costs and exceptional items was INR 20.879 million compared to INR 15.027 million a year ago. Profit from ordinary activities before tax was INR 20.660 million compared to INR 14.857 million a year ago. Net profit for the period was INR 16.706 million compared to INR 15.624 million a year ago. Basic and diluted earnings per share was INR 0.74 compared to INR 0.69 a year ago. For the full year, the company reported sales/income from operations of INR 428.146 million compared to INR 386.623 million a year ago. Profit from operations before other Income, finance costs and exceptional items was INR 41.340 million compared to INR 36.925 million a year ago. Profit from ordinary activities before tax was INR 41.086 million compared to INR 36.744 million a year ago. Net profit for the period was INR 34.563 million compared to INR 33.340 million a year ago. Basic and diluted earnings per share were INR 1.53 compared to INR 1.48 a year ago.